HomeJohnson & Johnson

Johnson & Johnson

JNJ Stock: Is it Appealing at a 52-Week Low?

JNJ Stock: Is it Appealing at a 52-Week Low?

March 1, 2023

JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations

JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations

October 20, 2022

Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

October 19, 2022

JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

October 10, 2022

Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot

September 28, 2022

Three Long Term Dividend Stocks to Buy

Three Long Term Dividend Stocks to Buy

September 15, 2022

Johnson & Johnson (JNJ) Stock: A High-Value Dividend Stock

September 15, 2022

Johnson & Johnson stock rose with the announcement of a $5 billion share buyback program and repeated profit targets.

September 14, 2022

Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines

August 29, 2022

Johnson & Johnson attempts to extend its “Texas two-step” in order to end talc litigation in two states

August 22, 2022

« 1 2 3 »